skip to content

Department of Pharmacology

 

Curious about entrepreneurship and research?

Next term we will be running a Department event to increase awareness of entrepreneurship and help people explore the potential of research from the groups here.

The event will be relaxed and encouraging, unlike Dragons' Den; a chance to explore ideas and gain skills.

All Department members are encouraged to attend and contribute.

Schedule:
First event: Next Pharma Phenomenon introduction

Tues 24th October 2023 3-4 pm, Pharmacology seminar room

  • A presentation provides an introduction on what is needed to form a spin-out, spin-out experiences, and how to assemble a pitch-deck.
  • We will briefly talk about patenting and Cambridge Enterprise will introduce how they can help in translation of research from the Department
  • Existing spin-outs will be discussed, related to the research area of groups in the Department.
  • Afterwards, there will be a drinks session to discuss and help to form teams.
  • Anyone is welcome.

The goal is to make it very simple to put together a pitch for a potential company with 4 or 5 hours of work.

Second event: Next Pharma Phenomenon pitching event

Tues 7th November 2023 3-4:30pm, Pharmacology seminar room

  • Each team gives a 10 min pitch, then questions from the panel (internal to the Department) and from the audience.
  • All the audience gets Pharmabucks to invest in their favourite teams.
  • Awarding of prizes for most popular pitch, judges' choice, and most insightful question.
  • This second event is for Dept members only, so the presentation will not count as public disclosure of any intellectual property.

Feel free to start building a team and thinking of company ideas before the first presentation in October. However, we expect that most teams will form after the first presentation.

Here is a spreadsheet of some examples of small and medium-sized companies, related to the research area of every group in the Department. They should be useful for inspiration, to look at their technology and business model.